While CDKN2A deleterious alterations (highly recurrent in B cell lymphomas) have been shown to recur in systemic T cell lymphomas [16], our patient had a neutral copy number for this gene. This evidence concerns the gene CDKN2A and B-cell non-Hodgkin lymphoma.